Skip to the content
  • Suomeksi
  • About Us
    • > Our role
    • > BoD and management
    • > Sustainability
  • Pharma Sector
    • > Feasibilities and inquiries
    • > Research archive
    • > References for post-licensure studies
  • Newsfeed
  • Contacts
  • Suomeksi

Tag: pneumococcal vaccine

  • In category NewsPosted on 30.03.2018

    Vaccine-preventable disease incidence of pneumococcal conjugate vaccine in the Finnish invasive pneumococcal disease vaccine trial

    Streptococcus pneumoniae, pneumococcus, causes a number of different clinical syndromes including invasive diseases like meningitis and sepsis/bacteraemia, pneumonia and upper respiratory infections like otitis media in children and sinusitis in adults. The disease burden is highest among infants and the elderly. Pneumococcus remains the number one killer in developing countries, especially due to the high disease burden of pneumonia, but mortality […]

  • About Us
    • Our role
    • BoD and management
    • Sustainability
  • Pharma Sector
    • Feasibilities and inquiries
    • Research archive
    • References for post-licensure studies
  • Newsfeed
  • Contacts

FVR - Finnish Vaccine Research
Peltokatu 26, 33100 Tampere, Finland
info@fvr.fi Business ID FI32566594

  • About cookies

© Copyrights 2022 FVR – Finnish Vaccine Research